Linezolid for Drug-Resistant Tuberculosis

Affiliations

¹ From the Oxford University Clinical Research Unit, Ho Chi Minh City (G.T.), and the National Lung Hospital and the Vietnam National Tuberculosis Program, Hanoi (N.V.N.) - all in Vietnam; and the Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom (G.T.).

Editorial

Guy Thwaites et al. N Engl J Med. 2022.

. 2022 Sep 1;387(9):842-843.

doi: 10.1056/NEJMe2208554.

¹ From the Oxford University Clinical Research Unit, Ho Chi Minh City (G.T.), and the National Lung Hospital and the Vietnam National Tuberculosis Program, Hanoi (N.V.N.) - all in Vietnam; and the Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom (G.T.).

No abstract available

Comment on

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, Samoilova A, Skornykova S, Tudor E, Variava E, Yablonskiy P, Everitt D, Wills GH, Sun E, Olugbosi M, Egizi E, Li M, Holsta A, Timm J, Bateson A, Crook AM, Fabiane SM, Hunt R, McHugh TD, Tweed CD, Foraida S, Mendel CM, Spigelman M; ZeNix Trial Team. Conradie F, et al. N Engl J Med. 2022 Sep 1;387(9):810-823. doi: 10.1056/NEJMoa2119430. N Engl J Med. 2022. PMID: 36053506 Free PMC article. Clinical Trial.